Premature ovarian failure and body composition changes with adjuvant chemotherapy for breast cancer

Menopause

Volumn 18, Issue 11, 2011, Pages 1244-1248

  Gordon, Angela M ^a   Hurwitz, Shelley ^a   Shapiro, Charles L ^b   Leboff, Meryl S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Body composition; Breast cancer; Chemotherapy; Ovarian failure

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOLLITROPIN; METHOTREXATE; PACLITAXEL; TAMOXIFEN;

AMENORRHEA; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; BONE DENSITY; BREAST CANCER; CALORIC INTAKE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CHEMOTHERAPY INDUCED OVARY FAILURE; CLINICAL ARTICLE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; EVALUATION AND FOLLOW UP; FEMALE; FEMUR NECK; FOLLITROPIN BLOOD LEVEL; HUMAN; LEAN BODY WEIGHT; OVARY FUNCTION; OVARY INSUFFICIENCY; WEIGHT GAIN; WEIGHT REDUCTION;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY COMPOSITION; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; METHOTREXATE; MIDDLE AGED; PREMENOPAUSE; PRIMARY OVARIAN INSUFFICIENCY; PROSPECTIVE STUDIES; TAMOXIFEN; WEIGHT GAIN;

EID: 80255138156     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31821b849b     Document Type: Article

References (26)

1. Shapiro CL, Manola J, Leboff M. Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer. J Clin Oncol 2001;19:3306-3311. (Pubitemid 32642182)
2. Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006;24:5769-5779. (Pubitemid 46646480)
3. Demark-Wahnefried W, Winer EP, Rimer BK. Why women gain weight with adjuvant chemotherapy for breast cancer. J Clin Oncol 1993;11: 1418-1429. (Pubitemid 23199148)
4. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol 1990; 8:1327-1334. (Pubitemid 20252304)
5. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol 2005;23:1370-1378.
6. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-1143. (Pubitemid 34141858)
7. Demark-Wahnefried W, Hars V, Conaway MR, et al. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr 1997;65:1495-1501. (Pubitemid 27187763)
8. Demark-Wahnefried W, Peterson BL, Winer EP, et al. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2001;19:2381-2389. (Pubitemid 32391208)
9. Freedman RJ, Aziz N, Albanes D, et al. Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer. J Clin Endocrinol Metab 2004;89:2248-2253. (Pubitemid 38619860)
10. Irwin ML, McTiernan A, Baumgartner RN, et al. Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol 2005;23:774-782. (Pubitemid 46224176)
11. Cheney CL, Mahloch J, Freeny P. Computerized tomography assessment of women with weight changes associated with adjuvant treatment for breast cancer. Am J Clin Nutr 1997;66:141-146. (Pubitemid 27278912)
12. Harvie MN, Campbell IT, Baildam A, Howell A. Energy balance in early breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 2004;83:201-210. (Pubitemid 38264868)
13. Svendsen OL, Hassager C, Christiansen C. Age-and menopauseassociated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism 1995;44:369-373.
14. Tremollieres FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol 1996;175:1594-1600. (Pubitemid 27021033)
15. Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause-related changes in body fat distribution. Ann N Y Acad Sci 2000;904:502-506. (Pubitemid 30389242)
16. Chen Z, Bassford T, Green SB, et al. Postmenopausal hormone therapy and body compositionVa substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutr 2005;82: 651-656.
17. Goodwin PJ, Ennis M, Pritchard KI, et al. Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis. J Clin Oncol 1999;17:120-129. (Pubitemid 29022385)
18. Kumar NB, Cantor A, Allen K, Cox CE. Android obesity at diagnosis and breast carcinoma survival: evaluation of the effects of anthropometric variables at diagnosis, including body composition and body fat distribution and weight gain during life span, and survival from breast carcinoma. Cancer 2000;88:2751-2757. (Pubitemid 30417935)
19. Borugian MJ, Sheps SB, Kim-Sing C, et al. Waist-to-hip ratio and breast cancer mortality. Am J Epidemiol 2003;158:963-968. (Pubitemid 37413395)
20. LeBoff MS, Kohlmeier L, Hurwitz S, Franklin J, Wright J, Glowacki J. Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA 1999;281:1505-1511. (Pubitemid 29200934)
21. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-469. (Pubitemid 16047362)
22. McTiernan A, Rajan KB, Tworoger SS, et al. Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol 2003;21: 1961-1966. (Pubitemid 46606384)
23. McTiernan A, Wu L, Chen C, et al. Relation of BMI and physical activity to sex hormones in postmenopausal women. Obesity (Silver Spring) 2006; 14:1662-1677. (Pubitemid 46214834)
24. Belfiore A, Frasca F. IGF and insulin receptor signaling in breast cancer. J Mammary Gland Biol Neoplasia 2008;13:381-406.
25. Goodwin PJ, Ennis M, Pritchard KI, et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002;20:42-51. (Pubitemid 34032594)
26. Pasanisi P, Berrino F, De Petris M, Venturelli E, Mastroianni A, Panico S. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 2006;119:236-238.